Management of gastric varices

Journal of Gastroenterology and Hepatology (Australia)

Volumn 26, Issue SUPPL. 1, 2011, Pages 102-108

  Hashizume, Makoto ^a   Akahoshi, Tomohiko ^a   Tomikawa, Morimasa ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

B RTO; Classification; Devascalarization; Gastric varices; Splenectomy

Indexed keywords

BUCRILATE; CYANOACRYLATE; ENBUCRILATE; FIBRIN GLUE; SCLEROSING AGENT; THROMBIN;

BALLOON OCCLUDED RETROGRADE TRANSVENOUS OBLITERATION; CATHETER; DEVASCULARIZATION; ENDOSCOPIC SCLEROTHERAPY; ESOPHAGOSCOPY; ESOPHAGUS VARICES BLEEDING; HEMODYNAMICS; HUMAN; INCIDENCE; MORTALITY; MULTIDETECTOR COMPUTED TOMOGRAPHY; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; REVIEW; SPLENECTOMY; STOMACH HEMORRHAGE; STOMACH VARICES; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT;

EID: 78650793612     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2010.06572.x     Document Type: Review

References (51)

1. Sarin SK, Lahoti D, Saxena SP et al. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology 1992; 16: 1343-9.
2. Greig JD, Garden OJ, Anderson JR et al. Management of gastric variceal haemorrhage. Br. J. Surg. 1990; 77: 297-9.
3. Hashizume M, Kitano S, Yamaga H et al. Endoscopic classification of gastric varices. Gastrointest. Endosc. 1990; 36: 276-80.
4. Ryan BM, Stockbrugger RW, Ryan JM. Review article: a pathophysiologic, gastroenterologic, and radiologic approach to the management of gastric varices. Gastroenterology 2004; 126: 1175-89.
5. Sorbi D, Gostout CJ, Peura D et al. An assessment of the management of acute bleeding varices: a multicenter prospective member-based study. Am. J. Gastroenterol. 2003; 98: 2424-34.
6. Ferguson JW, Tripathi D, Hayes PC. Review article: the management of acute variceal bleeding. Aliment. Pharmacol. Ther. 2003; 18: 253-62.
7. Seewald S, Mendoza G, Seitz U, Salem O, Soehendra N. Variceal bleeding and portal hypertension: has there been any progress in the last 12 months? Endoscopy 2003; 35: 136-44. Review.
8. McCormick PA, O'Keefe C. Improving prognosis following a first variceal haemorrhage over four decades. Gut 2001; 49: 682-5.
9. Imperiale TF, Chalasani N. A meta-analysis of endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleeding. Hepatology 2001; 33: 802-7.
10. Watanabe K, Kimura K, Matsutani S et al. Portal hemodynamics in patients with gastric varices: a study in 230 patients with esophageal and /or gastric varices using portal vein catheterization. Gastroenterology 1988; 95: 434-40.
11. Matsumoto A, Kitamoto M, Imamura M et al. Three-dimensional portography using multislice helical CT is clinically useful for management of gastric fundic varices. AJR Am. J. Roentgenol. 2001; 176: 899-905.
12. Hashimoto N, Akahoshi T, Yoshida D et al. The efficacy of balloon-occluded retrograde transvenous obliteration on small intestinal variceal bleeding. Surgery 2010; 148: 145-50.
13. Ninoi T, Nishida N, Kaminou T et al. Balloon-occluded retrograde transvenous obliteration of gastric varices with gastrorenal shunt: long-term follow-up in 78 patients. AJR Am. J. Roentgenol. 2005; 184: 1340-6.
14. Fukuda T, Hirota S, Sugimura K. Long-term results of balloon-occluded retrograde transvenous obliteration for thetreatment of gastric varices and hepatic encephalopathy. J. Vasc. Interv. Radiol. 2001; 12: 327-36.
15. Akahoshi T, Hashizume M, Tomikawa M et al. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding and risky gastric varices: a 10-year experience. J. Gastroenterol. Hepatol. 2008; 23: 1702-9.
16. Chin KJ, Ko Y, Yamada S. Demonstration of two distinct subsets of gastric varices: observations during a seven-year study of endoscopic sclerotherapy. Dig. Dis. Sci. 1991; 36: 303-9.
17. Trudeau W, Prindiville T. Endoscopic injection sclerosis in bleeding gastric varices. Gastrointest. Endosc. 1986; 32: 264-8.
18. Kanagawa H, Mima S. Kouyama H et al. Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration. J. Gastroenterol. Hepatol. 1996; 11: 51-8.
19. D'Imperio N, Piemontese A, Baroncini D et al. Evaluation of undiluted N-butyl-2-cyanoacrylate in the endoscopic treatment of upper gastrointestinal tract varices. Endoscopy 1996; 28: 239-43.
20. Lo GH, Lai KH, Cheng JS et al. A prospective, randomized trial of butyl cyanoacrylate injection versus band ligation in the management of bleeding gastric varices. Hepatology 2001; 33: 1060-4.
21. Kind R, Gugkielmi A, Rodella L et al. Bucrylate treatment of bleeding gastric varices; 12 years' experience. Endoscopy 2000; 32: 512-19.
22. Huang YH, Yeh HZ, Chen GH et al. Endoscopic treatment of bleeding gastric varices by N-butyl-2-cyanoacrylate (Histoacryl) injection: long-term efficacy and safety. Gastrointest. Endosc. 2000; 52: 160-7.
23. Akahoshi T, Hashizume M, Shimabukuro R et al. Long-term result of endoscopic histoacryl injection sclerotherapy for gastric variceal bleeding. Surgery 2002; 131: S177-81.
24. De Franchis R. 19. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J. Hepatol. 2005; 43: 167-76. No abstract available. Erratum in: J Hepatol. 2005;43: 547.
25. Sarin SK, Jain AK, Jain M, Gupta R. A randomized controlled trial of cyanoacrylate versus alcohol injection in patients with isolated fundic varices. Am. J. Gastroenterol. 2002; 97: 1010-15.
26. Tan PC, Hou MC, Lin HC et al. A randomized trial of endoscopic treatment of acute gastric variceal hemorrhage: n-butyl-2-cyanoacrylate injection versus band ligation. Hepatology 2006; 43: 690-7.
27. Lo GH, Liang HL, Chen WC et al. A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding. Endoscopy 2007; 39: 679-85.
28. Mishra SR, Chander Sharma B, Kumar A, Sarin SK. Endoscopic cyanoacrylate injection versus beta-blocker for secondary prophylaxis of gastric 20 variceal bleed: a randomised controlled trial. Gut 2010; 59: 729-35.
29. Yang WL, Tripathi D, Therapondos G, Todd A, Hayes PC. Endoscopic use of human thrombin in bleeding gastric varices. Am. J. Gastroenterol. 2002; 97: 1381-5.
30. Ramesh J, Limdi JK, Sharma V, Makin AJ. The use of thrombin injections in the management of bleeding gastric varices: a single-center experience. Gastrointest. Endosc. 2008; 68: 877-82.
31. Datta D, Vlavianos P, Alisa A, Westaby D. Use of fibrin glue (beriplast) in the management of bleeding gastric varices. Endoscopy 2003; 35: 675-8.
32. Heneghan MA, Byrne A, Harrison PM. An open pilot study of the effects of a human fibrin glue for endoscopic treatment of patients with acute bleeding from gastric varices. Gastrointest. Endosc. 2002; 56: 422-6.
33. Shiha G, El-Sayed SS. Gastric variceal ligation: a new technique. Gastrointest. Endosc. 1999; 49: 437-41.
34. Lee MS, Cho JY, Cheon YK et al. Use of detachable snares and elastic bands for endoscopic control of bleeding from large gastric varices. Gastrointest. Endosc. 2002; 56: 83-8.
35. Azoulay D, Castaing D, Majno P et al. Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis. J. Hepatol. 2001; 35: 590-7.
36. Tripathi D, Therapondos G, Jackson E et al. The role of the transjugular intrahepatic portosystemic stent shunt (TIPSS) in the management of bleeding gastric varices: clinical and haemodynamic correlations. Gut 2002; 51: 270-4.
37. Chau TN, Patch D, Chan YW, Nagral A, Dick R, Burroughs AK. Salvage transjugular intrahepatic portosystemic shunts-Gastric fundal compared with esophageal variceal bleeding. Gastroenterology 1998; 114: 981-7.
38. Clark W, Hernandez J, McKeon B et al. Surgical shunting versus transjugular intrahepatic portasystemic shunting for bleeding varices resulting from portal hypertension and cirrhosis: a meta-analysis. Am. Surg. 2010; 76: 857-64.
39. Hassab MA. Gastroesophageal decongestion and splenectomy in the treatment of esophageal varices in bilharzial cirrhosis: further studies with a report on 355 operations. Surgery 1967; 61: 169-76.
40. Tomikawa M, Hashizume M, Saku M, Tanoue K, Ohta M, Sugimachi K. Effectiveness of gastric devascularization and splenectomy for patients with gastric varices. J. Am. Coll. Surg. 2000; 191: 498-503.
41. Sugo H, Fujiwara N, Yoshimoto J, Miwa K, Ishizaki Y. Additional Hassab's operation for esophagogastric varices in cirrhotic patients with resectable hepatocellular carcinoma. Hepatogastroenterology 2008; 55: 1686-90.
42. Hashizume M, Tanoue K, Morita M, Ohta M, Tomikawa M, Sugimachi K. Laparoscopic gastric devascularization and splenectomy for sclerotherapy-resistant esophagogastric varices with hypersplenism. J. Am. Coll. Surg. 1998; 187: 263-70.
43. Yamamoto J, Nagai M, Smith B et al. Hand-assisted laparoscopic splenectomy and devascularization of the upper stomach in the management of gastric varices. World J. Surg. 2006; 30: 1520-5.
44. Akahoshi T, Tomikawa M, Korenaga D et al. Laparoscopic splenectomy with peginterferon and ribavirin therapy for patients with hepatitis C virus cirrhosis and hypersplenism. Surg. Endosc. 2010; 24: 680-5.
45. Arai H, Abe T, Shimoda R, Takagi H, Yamada T, Mori M. Emergency balloon-occluded retrograde transvenous obliteration for gastric varices. J. Gastroenterol. 2005; 40: 964-71.
46. Hiraga N, Aikata H, Takaki S et al. The long-term outcome of patients with bleeding gastric varices after balloon-occluded retrograde transvenous obliteration. J. Gastroenterol. 2007; 42: 663-72.
47. Chikamori F, Kuniyoshi N, Shibuya S et al. Eight years of experience with transjugular retrograde obliteration for gastric varices with gastrorenal shunt. Surgery 2001; 129: 414-20.
48. Akahane T, Iwasaki T, Kobayashi N et al. Changes in liver function parameters after occlusion of gastrorenal shunts with balloon-occluded retrograde transvenous obliteration. Am. J. Gastroenterol. 1997; 92: 1026-30.
49. Miyamoto Y, Oho K, Kumamoto M et al. Balloon-occluded retrograde transvenous obliteration improves liver function in patients with cirrhosis and portal hypertension. J. Gastroenterol. Hepatol. 2003; 18: 934-42.
50. Kiyosue H, Mori H, Matsumoto S, Yamada Y, Hori Y, Okino Y. Transcatheter obliteration of gastric varices: part 2. Strategy and techniques based on hemodynamic features. Radiographics 2003; 23: 921-37.
51. Choi SY, Won JY, Kim KA, Lee DY, Lee KH. Foam sclerotherapy using polidocanol for balloon-occluded retrograde transvenous obliteration (BRTO). Eur. Radiol. 26 August 2010 [Epub ahead of print].